I.
Purpose
The Purpose of the
investigation is to determine the cause of the Out Of Specification results.
II. SCOPE
This procedure is applicable in Raw
Material, Finished Product and Intermediates and Stability Study results. This
procedure is not applicable for following:
-
Microbiological
analysis results
-
Results of
In-process samples for monitoring the manufacturing operation.
III. Responsibility
QC Assistant, QC Executive, QC
Manager, QA Manager, Production Manager.
IV. Accountability
Head QA
V. Procedure
1.0
If any result,
reading, measurement is obtained out of the established limit, it should be
investigated as follows
2.0
Phase I Investigation
2.1
While carrying
out the analysis, if any result is found out of specification, analyst should
preserve the samples, standards, and dilutions.
2.2
Analyst should
inform immediately to Head QC.
2.3
Investigation
should be carried out as per the Format No.: F01/SOPQA023-00.
2.4
If any
instrument or analyst error is identified, QC Head should take necessary
corrective actions to rectify the error and take decision of retesting.
2.5
If the sample is
not sufficient for analysis, analyst should resample in presence of QA person.
2.6
Retesting should
be done by a different analyst using fresh solutions.
2.7
If the error is
due to the following reasons
2.7.1
Improper
sampling
2.7.2
Sample
contamination
2.7.3
Calibration
error
2.7.4
Having not
followed SOP for sampling.
2.8
Incase the error
is not identified in laboratory, then proceed for production and warehouse
investigation.
2.9
The
investigation should be carried out as per Phase II investigation.
2.10
After phase
investigation by Head QA, corrective measures should be recommended
2.11
error found is
identified then the retest results
should be substituted for the previous results.
2.12
RerAnalyst will
resample as per SOP.
2.13
If the problem
is due to the improper maintenance of instrument, or due to
2.14
Incase of error
found in laboratory investigation, the sample should be retested.
2.15
2.15.1 Retrain the QC Chemist, if the OOS is attributed to
personal error. Document training procedures.
Responsibility: Sr. QC Executive / QC Manager
2.16
Retest /
Resample
2.16.1 If an assignable cause related to Laboratory error
(like sample preparation, analytical method, equipment or analyst etc.) is
established using the initial aliquots of test solutions, the OOS result may be
INVALIDATED, and cause will be documented.
2.16.2 Retest using same solutions of test preparations may
be performed, and if the results meet specification, the subject batch may be
RELEASED.
2.16.3 If the initial OOS results are not assigned to
original solutions of test preparations, analyst error etc., Retest from the
original portions of sample drawn may be performed after the same is authorized
by QC Manager / Supervisor. Retesting
may be performed by the same analyst or a different Analyst other than the one
performed original test. The Retest is
carried out to evaluate if OOS observation was due to,
2.16.3.1
Error in
weighment leading to error in Test Preparations.
2.16.3.2
Analyst Error.
2.16.3.3
Or any other
parameter related to Test method used, Equipment Calibration etc.
2.16.4 Retesting from same portion of sample is performed
in triplicate and if all individual results meet the intended specification and
if none of the individual results are out of specification, results may be
averaged.
2.16.5 If such retest results meet the specifications,
cause of original OOS must be investigated. If the cause can be assigned to a
definite Analytical Error with specificity to certain area of retesting, and
the OOS is NOT related to manufacturing process, then original OOS may be
INVALIDATED.
2.16.6 Depending upon the nature of Analytical error, a
review should be performed, if such errors have past history.
2.16.7 Accordingly, review of Analytical Method, Equipment
Calibration, or Retraining of Analyst may be performed.
2.16.8 Complete review of this investigation should be
documented, to minimize re-occurrence of such incidents in future.
2.16.9 Re-sampling may be permitted ONLY IF, retest data
from the original portion of the sample as carried out under section 3.2.3 and
the subsequent investigation gives possible evidence in respect of errors in
Sampling. However, in case of OOS of outsourced Raw Materials, intermediates
and re-sampling may be performed even if there is no evidence suspected in sampling errors primarily to support the
original OOS data.
2.16.10 Re-sampling may be performed after due authorization
of QC Manager after he has
established that, all previous data using original portion of sample has been
evaluated, and concluded that, the original sample was NOT drawn as per
standard sampling procedure and therefore this sample was NOT truly
representative of the batch being tested.
e. g.
Non representativeness of original sample is indicated by wide variation
in results from several aliquots of the original sample as
indicated
under 3.2.11.
2.16.11 Re-sampling if permitted, should be performed using
the same sampling procedure either by the same Analyst or by a different
Analyst.
2.16.12 Evaluation of data from re-sampled material should
be performed to determine if original sample was NOT representative. If there
is adequate evidence to support errors in initial sampling like
contamination or wrong identification etc., and if it is established
unambiguously that original OOS results were due to Faulty Sampling or Errors
in Sampling Procedure, then only the original OOS results can be INVALIDATED.
If the investigation determines that the
initial sampling method had indeed errors, a new accurate and representative
sampling method must be developed, qualified, and documented.
2.16.13 Testing of re-sampled aliquot should be performed by
in triplicate to establish new basis for batch release.
2.16.14 If each of 3 such data as well as the Average of
these results meets specifications, original OOS result is INVALIDATED, and
batch may be considered for RELEASE.
While taking such a decision, it should be equately established that
there are NO FAILURES in Manufacturing Process, by conducting a review of Batch
Production Record.
2.16.15 Out of three individual analyses, if any single
preparation analysis fails the sample shall be rejected.
2.16.16 All steps leading to OOS investigations should be
documented and review
of each failure should be correlated to
occurrence of similar failures in the past.
An action plan should be prepared depending upon the nature of failure
found which caused OOS.
2.16.17 If no assignable cause is found till this stage, the
original OOS results should be considered VALID and the subject batch should be
REJECTED.
2.16.18 For further detailed investigation into OOS result,
Phase II investigation should be initiated to determine the cause of failures
in manufacturing process.
3.2.19 In case of out of specification in
“Description” test, the retest analysis is not required in triplicate, the
description test will be tested for single time and batch can be decided based
on single time analysis in retest.
2.17
Interpretation
of Data
2.17.1 Pass lot when all retest or re-samples pass.
Responsibility: QC Executive
2.17.2 For results originally out of the specification
ranges, reject the lot when any retest or resample fails (the OOS result has
been confirmed).
Responsibility: QC Executive
In case of raw material
after retesting the same material if it is rejected and material send back to
party then no further investigation is required.
Responsibility: QC Chemist
3.0
Phase II investigation
3.1
If an Assignable
cause could not be established during the Phase I investigation, or retest
results were found to be out of specification, a review of Manufacturing
Process of the subject batch should be carried out to identify the cause of
Failure.
3.2
Phase II
investigation is carried out by a Group consisting of
·
Manager QC/QA
·
Manager
Production
3.3
Such an
investigation consists of complete review / evaluation in to potential
manufacturing causes of the OOS results.
3.4
Evaluation of
Batch Production Records related to the subject batch.
3.5
Trend analysis
of previous batches if there is any evidence to indicate Failures prior to
observation of OOS result and also to assess the impact of failure on previous
lots.
Note:
Phase II investigation may be performed parallel to Phase I Investigation.
4.0
Information
included in the Phase II investigation report is reviewed by a Group chaired by the Production Manager, QA Manager
and QC Manager. Phase II investigation
report is approved by QA Head. It is responsibility of this Group to establish and document the cause of Failure
and also recommend corrective action plan
to prevent recurrence of such Failures in future. This Group also is responsible to evaluate if there is any impact on preceding or
succeeding lots of this product.
5.0
Documentation
All documents related
to the lot or batch in question are compiled by Quality Control / Quality Assurance / Production Department and
reports of all such investigations are
filed separately and maintained by Manager QA. QA will maintain the OOS log as per Format No. F03/SOPQA023-00.
6.0
After completion
of investigation, if it rejected, the “Discrepancy / Rejection Memo” note shall
be sent to purchase department having the following details.
- Material :
- Challan No / Date :
- Invoice No / Date :
- Challan Quantity :
- Quantity Received :
- Discrepancy :
7.0
Time frame
All OOS investigations
should be completed within 30 days of finding an OOS result. An extension of
this 30 days period can be authorized in writing if needed
|
|
|
|
|
Thanks a lot for helping the QA people with these type of articles for ready reference and instantly .
ReplyDeleteThis comment has been removed by the author.
ReplyDeleteThank you for sharing this blog it is very nice and very informative. I would like to share with you about Acute/Subacute Preclinical Studies in which a drug is tested on animals and in other non-human test systems.
ReplyDelete